Literature DB >> 27444300

The effect of taurine and β-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice.

Deanna M Horvath1, Robyn M Murphy2, Janelle P Mollica3, Alan Hayes4,5,6, Craig A Goodman4,5.   

Abstract

This study investigated the effect of taurine and β-alanine supplementation on muscle function and muscle taurine transporter (TauT) protein expression in mdx mice. Wild-type (WT) and mdx mice (5 months) were supplemented with taurine or β-alanine for 4 weeks, after which in vitro contractile properties, fatigue resistance and force recovery, and the expression of the TauT protein and proteins involved in excitation-contraction (E-C) coupling were examined in fast-twitch muscle. There was no difference in basal TauT protein expression or basal taurine content between mdx than WT muscle. Supplementation with taurine and β-alanine increased and reduced taurine content, respectively, in muscle from WT and mdx mice but had no effect of TauT protein. Taurine supplementation reduced body and muscle mass, and enhanced fatigue resistance and force recovery in mdx muscle. β-Alanine supplementation enhanced fatigue resistance in WT and mdx muscle. There was no difference in the basal expression of key E-C coupling proteins [ryanodine receptor 1 (RyR1), dihydropyridine receptor (DHPR), sarco(endo)plasmic reticulum Ca2+-ATPase 1 (SERCA1) or calsequestrin 1 (CSQ1)] between WT and mdx mice, and the expression of these proteins was not altered by taurine or β-alanine supplementation. These findings suggest that TauT protein expression is relatively insensitive to changes in muscle taurine content in WT and mdx mice, and that taurine and β-alanine supplementation may be viable therapeutic strategies to improve fatigue resistance of dystrophic skeletal muscle.

Entities:  

Keywords:  Duchene muscular dystrophy; Excitation–contraction coupling; Muscle fatigue; Skeletal muscle; Taurine supplementation

Mesh:

Substances:

Year:  2016        PMID: 27444300     DOI: 10.1007/s00726-016-2292-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  10 in total

1.  A Systematic Risk Assessment and Meta-Analysis on the Use of Oral β-Alanine Supplementation.

Authors:  Eimear Dolan; Paul A Swinton; Vitor de Salles Painelli; Benedict Stephens Hemingway; Bruna Mazzolani; Fabiana Infante Smaira; Bryan Saunders; Guilherme G Artioli; Bruno Gualano
Journal:  Adv Nutr       Date:  2019-05-01       Impact factor: 8.701

2.  Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Gavin J Pinniger; Jessica R Terrill; Evanna B Assan; Miranda D Grounds; Peter G Arthur
Journal:  J Physiol       Date:  2017-09-30       Impact factor: 5.182

3.  Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction.

Authors:  Jessica R Terrill; Gavin J Pinniger; Keshav V Nair; Miranda D Grounds; Peter G Arthur
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

4.  Alterations of gut microbiota contribute to the progression of unruptured intracranial aneurysms.

Authors:  Hao Li; Haochen Xu; Youxiang Li; Yuhua Jiang; Yamin Hu; Tingting Liu; Xueqing Tian; Xihai Zhao; Yandong Zhu; Shuxia Wang; Chunrui Zhang; Jing Ge; Xuliang Wang; Hongyan Wen; Congxia Bai; Yingying Sun; Li Song; Yinhui Zhang; Rutai Hui; Jun Cai; Jingzhou Chen
Journal:  Nat Commun       Date:  2020-06-25       Impact factor: 14.919

Review 5.  Energy Drinks and Sports Performance, Cardiovascular Risk, and Genetic Associations; Future Prospects.

Authors:  Jorge Gutiérrez-Hellín; David Varillas-Delgado
Journal:  Nutrients       Date:  2021-02-24       Impact factor: 5.717

Review 6.  The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy.

Authors:  Caroline Merckx; Boel De Paepe
Journal:  Metabolites       Date:  2022-02-19

7.  Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse.

Authors:  Caroline Merckx; Jana Zschüntzsch; Stefanie Meyer; Robrecht Raedt; Hanne Verschuere; Jens Schmidt; Boel De Paepe; Jan L De Bleecker
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

Review 8.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

Review 9.  Taurine Reverses Oxidative Damages and Restores the Muscle Function in Overuse of Exercised Muscle.

Authors:  Anand Thirupathi; Ricardo A Pinho; Julien S Baker; Bíró István; Yaodong Gu
Journal:  Front Physiol       Date:  2020-10-26       Impact factor: 4.566

10.  The Effect of Fermented Porcine Placental Extract on Fatigue-Related Parameters in Healthy Adults: A Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Dong Hyun Yoon; Ga-Young Han; Su Seung Hwang; Dong Won Lee; Jin-Soo Kim; Keunwon Kim; Jongbae Kim; Wook Song
Journal:  Nutrients       Date:  2020-10-11       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.